Get started
Award

1S32316N

Funded outputs count: 9
Funder award ID: 1S32316N
OpenAlex ID: G2016853584
Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer
2020 · Tal Flieswasser, Jinthe Van Loenhout, et al. · Cells · 57
PDF
Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment
2020 · Jonas RM Van Audenaerde, Elly Marcq, et al. · Clinical & Translational Immunology · 41
PDF
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells
2019 · Jinthe Van Loenhout, Tal Flieswasser, et al. · Cancers · 123
PDF
Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression
2019 · Elly Marcq, Jonas RM Van Audenaerde, et al. · International Journal of Molecular Sciences · 12
PDF
Tissue‐specific tumor microenvironments influence responses to immunotherapies
2019 · Amanda J Oliver, Ashleigh S Davey, et al. · Clinical & Translational Immunology · 35
PDF
Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade
2017 · Jorrit De Waele, Elly Marcq, et al. · OncoImmunology · 46
PDF
Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients
2017 · Elly Marcq, Jorrit De Waele, et al. · Oncotarget · 62
PDF
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma
2016 · Elly Marcq, Vasiliki Siozopoulou, et al. · OncoImmunology · 92
PDF
Cold atmospheric plasma treatment of melanoma and glioblastoma cancer cells
2016 · Stijn Vermeylen, Jorrit De Waele, et al. · Plasma Processes and Polymers · 67